Smart science to improve lives™
  • Login | Register

Cithrol™ GMO HP

High purity lipid-based drug delivery excipient offering the potential for enhanced bioavailability of actives coupled with controlled drug release. Its liquid crystalline structure in aqueous systems and ability to enhance membrane penetration enable Cithrol GMO HP to offer sustained drug release and greater active bioavailability for oral and topical dosage forms. Contains a minimum of 92% monoester and 88% oleic acid.
Cithrol™ GMO HP
To add to favourites please login Login

Product details

Pharmacopoeia compliance

  • FDA-IIG listed
  • PhEur

Chemical group

  • Ester
  • Polyol ester

Administration route

  • Oral
  • Topical

Market application

  • Dermatology
  • Human pharmaceutical
  • Veterinary health


  • Emulsifier
  • Emulsion stabiliser
  • Excipient
  • Penetration enhancer

Physical form

  • Off-white solid


  • 3.00
Would you like support from our in-house technical experts?